BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
Number Cited Articles
1
Jung Sun Yum, Byung Cheol Ahn, Hyun Jin Jo, Dong Yeon Kim, Ki Hyun Kim, Hyo Sun Kim, Young Chul Sung, Jaeseung Yoon, John Morrey, Hong Mo Moon. Use of Pre-S Protein-Containing Hepatitis B Virus Surface Antigens and a Powerful Adjuvant To Develop an Immune Therapy for Chronic Hepatitis B Virus InfectionClinical and Vaccine Immunology 2012; 19(2): 120 doi: 10.1128/CVI.05355-11
2
Sonia Alonso, Adriana-René Guerra, Lourdes Carreira, Juan-Ángel Ferrer, María-Luisa Gutiérrez, Conrado M. Fernandez-Rodriguez. Upcoming pharmacological developments in chronic hepatitis B: can we glimpse a cure on the horizon?BMC Gastroenterology 2017; 17(1) doi: 10.1186/s12876-017-0726-2
3
Gloria Gonzalez-Aseguinolaza, Julien Crettaz, Laura Ochoa, Itziar Otano, Rafael Aldabe, Astrid Paneda. Gene therapy for viral hepatitisExpert Opinion on Biological Therapy 2006; 6(12): 1263 doi: 10.1517/14712598.6.12.1263
4
A. S. Levina, E. A. Mikhaleva, M. N. Repkova, V. F. Zarytova. Synthesis of polyamine-containing oligonucleotidesRussian Journal of Bioorganic Chemistry 2008; 34(1): 80 doi: 10.1134/S1068162008010111
5
Kenward Vong, Katsunori Tanaka, Koichi Fukase. Handbook of In Vivo Chemistry in Mice2020; : 489 doi: 10.1002/9783527344406.ch17
6
Gaetan Billioud, Robert L. Kruse, Melissa Carrillo, Christina Whitten-Bauer, Dacao Gao, Aneeza Kim, Leon Chen, Michael L. McCaleb, Jeffrey R. Crosby, Robert Hamatake, Zhi Hong, Urtzi Garaigorta, Eric Swayze, Karl-Dimiter Bissig, Stefan Wieland. In vivo reduction of hepatitis B virus antigenemia and viremia by antisense oligonucleotidesJournal of Hepatology 2016; 64(4): 781 doi: 10.1016/j.jhep.2015.11.032
7
Shigeru Kawakami, Mitsuru Hashida. Glycosylation-mediated targeting of carriersJournal of Controlled Release 2014; 190: 542 doi: 10.1016/j.jconrel.2014.06.001